Matsela, L. M., & Cleary, S. (2022). Cost utility and budget impact analysis of bortezomib and lenalidomide for the treatment of relapsed/refractory multiple myeloma in the South African public health sector. Unknown.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Matsela, Lineo Marie, and Susan Cleary. Cost Utility and Budget Impact Analysis of Bortezomib and Lenalidomide for the Treatment of Relapsed/refractory Multiple Myeloma in the South African Public Health Sector. Unknown, 2022.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Matsela, Lineo Marie, and Susan Cleary. Cost Utility and Budget Impact Analysis of Bortezomib and Lenalidomide for the Treatment of Relapsed/refractory Multiple Myeloma in the South African Public Health Sector. Unknown, 2022.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.